View in EDS HTML Full Text PDF Full Text

Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study.

Saved in:
Bibliographic Details
Title: Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study.
Authors: Rass, Verena (AUTHOR), Beer, Ronny (AUTHOR), Schiefecker, Alois Josef (AUTHOR), Kofler, Mario (AUTHOR), Lindner, Anna (AUTHOR), Mahlknecht, Philipp (AUTHOR), Heim, Beatrice (AUTHOR), Limmert, Victoria (AUTHOR), Sahanic, Sabina (AUTHOR), Pizzini, Alex (AUTHOR), Sonnweber, Thomas (AUTHOR), Tancevski, Ivan (AUTHOR), Scherfler, Christoph (AUTHOR), Zamarian, Laura (AUTHOR), Bellmann‐Weiler, Rosa (AUTHOR), Weiss, Günter (AUTHOR), Djamshidian, Atbin (AUTHOR), Kiechl, Stefan (AUTHOR), Seppi, Klaus (AUTHOR), Loeffler‐Ragg, Judith (AUTHOR)
Source: European Journal of Neurology. Oct2021, Vol. 28 Issue 10, p3348-3359. 12p.
Subjects: Mental illness, COVID-19, MELAS syndrome, Quality of life, Neurological disorders, Neurologic manifestations of general diseases, Psychological manifestations of general diseases
Abstract: Background and purpose: To assess neurological manifestations and health‐related quality of life (QoL) 3 months after COVID‐19. Methods: In this prospective, multicenter, observational cohort study we systematically evaluated neurological signs and diseases by detailed neurological examination and a predefined test battery assessing smelling disorders (16‐item Sniffin Sticks test), cognitive deficits (Montreal Cognitive Assessment), QoL (36‐item Short Form), and mental health (Hospital Anxiety and Depression Scale, Posttraumatic Stress Disorder Checklist–5) 3 months after disease onset. Results: Of 135 consecutive COVID‐19 patients, 31 (23%) required intensive care unit (ICU) care (severe), 72 (53%) were admitted to the regular ward (moderate), and 32 (24%) underwent outpatient care (mild) during acute disease. At the 3‐month follow‐up, 20 patients (15%) presented with one or more neurological syndromes that were not evident before COVID‐19. These included polyneuro/myopathy (n = 17, 13%) with one patient presenting with Guillain‐Barré syndrome, mild encephalopathy (n = 2, 2%), parkinsonism (n = 1, 1%), orthostatic hypotension (n = 1, 1%), and ischemic stroke (n = 1, 1%). Objective testing revealed hyposmia/anosmia in 57/127 (45%) patients at the 3‐month follow‐up. Self‐reported hyposmia/anosmia was lower (17%) at 3 months, however, improved when compared to the acute disease phase (44%; p < 0.001). At follow‐up, cognitive deficits were apparent in 23%, and QoL was impaired in 31%. Assessment of mental health revealed symptoms of depression, anxiety, and posttraumatic stress disorders in 11%, 25%, and 11%, respectively. Conclusions: Despite recovery from the acute infection, neurological symptoms were prevalent at the 3‐month follow‐up. Above all, smelling disorders were persistent in a large proportion of patients. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 152468329
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neurological outcome and quality of life 3&#160;months after COVID‐19: A prospective observational cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Rass%2C+Verena%22&quot;&gt;Rass, Verena&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Beer%2C+Ronny%22&quot;&gt;Beer, Ronny&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Schiefecker%2C+Alois+Josef%22&quot;&gt;Schiefecker, Alois Josef&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kofler%2C+Mario%22&quot;&gt;Kofler, Mario&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lindner%2C+Anna%22&quot;&gt;Lindner, Anna&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mahlknecht%2C+Philipp%22&quot;&gt;Mahlknecht, Philipp&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Heim%2C+Beatrice%22&quot;&gt;Heim, Beatrice&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Limmert%2C+Victoria%22&quot;&gt;Limmert, Victoria&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Sahanic%2C+Sabina%22&quot;&gt;Sahanic, Sabina&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Pizzini%2C+Alex%22&quot;&gt;Pizzini, Alex&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Sonnweber%2C+Thomas%22&quot;&gt;Sonnweber, Thomas&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Tancevski%2C+Ivan%22&quot;&gt;Tancevski, Ivan&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Scherfler%2C+Christoph%22&quot;&gt;Scherfler, Christoph&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Zamarian%2C+Laura%22&quot;&gt;Zamarian, Laura&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Bellmann‐Weiler%2C+Rosa%22&quot;&gt;Bellmann‐Weiler, Rosa&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Weiss%2C+G&#252;nter%22&quot;&gt;Weiss, G&#252;nter&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Djamshidian%2C+Atbin%22&quot;&gt;Djamshidian, Atbin&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kiechl%2C+Stefan%22&quot;&gt;Kiechl, Stefan&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Seppi%2C+Klaus%22&quot;&gt;Seppi, Klaus&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Loeffler‐Ragg%2C+Judith%22&quot;&gt;Loeffler‐Ragg, Judith&lt;/searchLink&gt; (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22European+Journal+of+Neurology%22&quot;&gt;European Journal of Neurology&lt;/searchLink&gt;. Oct2021, Vol. 28 Issue 10, p3348-3359. 12p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Mental+illness%22&quot;&gt;Mental illness&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22COVID-19%22&quot;&gt;COVID-19&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22MELAS+syndrome%22&quot;&gt;MELAS syndrome&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Quality+of+life%22&quot;&gt;Quality of life&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Neurological+disorders%22&quot;&gt;Neurological disorders&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Neurologic+manifestations+of+general+diseases%22&quot;&gt;Neurologic manifestations of general diseases&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Psychological+manifestations+of+general+diseases%22&quot;&gt;Psychological manifestations of general diseases&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background and purpose: To assess neurological manifestations and health‐related quality of life (QoL) 3 months after COVID‐19. Methods: In this prospective, multicenter, observational cohort study we systematically evaluated neurological signs and diseases by detailed neurological examination and a predefined test battery assessing smelling disorders (16‐item Sniffin Sticks test), cognitive deficits (Montreal Cognitive Assessment), QoL (36‐item Short Form), and mental health (Hospital Anxiety and Depression Scale, Posttraumatic Stress Disorder Checklist–5) 3 months after disease onset. Results: Of 135 consecutive COVID‐19 patients, 31 (23%) required intensive care unit (ICU) care (severe), 72 (53%) were admitted to the regular ward (moderate), and 32 (24%) underwent outpatient care (mild) during acute disease. At the 3‐month follow‐up, 20 patients (15%) presented with one or more neurological syndromes that were not evident before COVID‐19. These included polyneuro/myopathy (n = 17, 13%) with one patient presenting with Guillain‐Barr&#233; syndrome, mild encephalopathy (n = 2, 2%), parkinsonism (n = 1, 1%), orthostatic hypotension (n = 1, 1%), and ischemic stroke (n = 1, 1%). Objective testing revealed hyposmia/anosmia in 57/127 (45%) patients at the 3‐month follow‐up. Self‐reported hyposmia/anosmia was lower (17%) at 3 months, however, improved when compared to the acute disease phase (44%; p &lt; 0.001). At follow‐up, cognitive deficits were apparent in 23%, and QoL was impaired in 31%. Assessment of mental health revealed symptoms of depression, anxiety, and posttraumatic stress disorders in 11%, 25%, and 11%, respectively. Conclusions: Despite recovery from the acute infection, neurological symptoms were prevalent at the 3‐month follow‐up. Above all, smelling disorders were persistent in a large proportion of patients. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=152468329
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ene.14803
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 3348
    Subjects:
      – SubjectFull: Mental illness
        Type: general
      – SubjectFull: COVID-19
        Type: general
      – SubjectFull: MELAS syndrome
        Type: general
      – SubjectFull: Quality of life
        Type: general
      – SubjectFull: Neurological disorders
        Type: general
      – SubjectFull: Neurologic manifestations of general diseases
        Type: general
      – SubjectFull: Psychological manifestations of general diseases
        Type: general
    Titles:
      – TitleFull: Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rass, Verena
      – PersonEntity:
          Name:
            NameFull: Beer, Ronny
      – PersonEntity:
          Name:
            NameFull: Schiefecker, Alois Josef
      – PersonEntity:
          Name:
            NameFull: Kofler, Mario
      – PersonEntity:
          Name:
            NameFull: Lindner, Anna
      – PersonEntity:
          Name:
            NameFull: Mahlknecht, Philipp
      – PersonEntity:
          Name:
            NameFull: Heim, Beatrice
      – PersonEntity:
          Name:
            NameFull: Limmert, Victoria
      – PersonEntity:
          Name:
            NameFull: Sahanic, Sabina
      – PersonEntity:
          Name:
            NameFull: Pizzini, Alex
      – PersonEntity:
          Name:
            NameFull: Sonnweber, Thomas
      – PersonEntity:
          Name:
            NameFull: Tancevski, Ivan
      – PersonEntity:
          Name:
            NameFull: Scherfler, Christoph
      – PersonEntity:
          Name:
            NameFull: Zamarian, Laura
      – PersonEntity:
          Name:
            NameFull: Bellmann‐Weiler, Rosa
      – PersonEntity:
          Name:
            NameFull: Weiss, Günter
      – PersonEntity:
          Name:
            NameFull: Djamshidian, Atbin
      – PersonEntity:
          Name:
            NameFull: Kiechl, Stefan
      – PersonEntity:
          Name:
            NameFull: Seppi, Klaus
      – PersonEntity:
          Name:
            NameFull: Loeffler‐Ragg, Judith
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2021
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 13515101
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: European Journal of Neurology
              Type: main
ResultId 1